{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T22:36:45Z","timestamp":1794523005126,"version":"4.9.1"},"reference-count":163,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,2,3]],"date-time":"2022-02-03T00:00:00Z","timestamp":1643846400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:p>A comprehensive review of published literature was conducted to elucidate the genetics, neuropathology, imaging findings, prevalence, clinical course, diagnosis\/clinical evaluation, potential biomarkers, and current and proposed treatments for adult-onset leukoencephalopathy with axonal spheroids and pigmented glia (ALSP), a rare, debilitating, and life-threatening neurodegenerative disorder for which disease-modifying therapies are not currently available. Details on potential efficacy endpoints for future interventional clinical trials in patients with ALSP and data related to the burden of the disease on patients and caregivers were also reviewed. The information in this position paper lays a foundation to establish an effective clinical rationale and address the clinical gaps for creation of a robust strategy to develop therapeutic agents for ALSP, as well as design future clinical trials, that have clinically meaningful and convergent endpoints.<\/jats:p>","DOI":"10.3389\/fneur.2021.788168","type":"journal-article","created":{"date-parts":[[2022,2,3]],"date-time":"2022-02-03T05:29:51Z","timestamp":1643866191000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":72,"title":["Adult-Onset Leukoencephalopathy With Axonal Spheroids and Pigmented Glia: Review of Clinical Manifestations as Foundations for Therapeutic Development"],"prefix":"10.3389","volume":"12","author":[{"given":"Spyros","family":"Papapetropoulos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Pontius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Finger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginija","family":"Karrenbauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David S.","family":"Lynch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Brennan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha","family":"Zappia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Koehler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludger","family":"Schoels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefanie N.","family":"Hayer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuya","family":"Konno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Ikeuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Troy","family":"Lund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Orthmann-Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Eichler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zbigniew K.","family":"Wszolek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,2,3]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1212\/WNL.0b013e31828726a7","article-title":"CSF1R mutations link POLD and HDLS as a single disease entity","volume":"80","author":"Nicholson","year":"2013","journal-title":"Neurol"},{"key":"B2","first-page":"21","article-title":"Le type tardif de la leucodystrophie progressive familiale","volume":"65","author":"Van Bogaert","year":"1936","journal-title":"Rev Neurol"},{"key":"B3","first-page":"1","article-title":"Hereditary diffuse leucoencephalopathy with spheroids","volume":"314","author":"Axelsson","year":"1984","journal-title":"Acta Psychiatr Scand Suppl"},{"key":"B4","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1186\/s40478-019-0843-y","article-title":"An AARS variant as the likely cause of Swedish type hereditary diffuse leukoencephalopathy with spheroids","volume":"7","author":"Sundal","year":"2019","journal-title":"Acta Neuropathol Commun"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1001\/jamaneurol.2016.2229","article-title":"Analysis of mutations in AARS2 in a series of CSF1R-negative patients with adult-onset leukoencephalopathy with axonal spheroids and pigmented glia","volume":"73","author":"Lynch","year":"2016","journal-title":"JAMA Neurol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1212\/WNL.0000000000006642","article-title":"CSF1R-related leukoencephalopathy: a major player in primary microgliopathies","volume":"91","author":"Konno","year":"2018","journal-title":"Neurol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"239","DOI":"10.5603\/PJNNS.a2021.0022","article-title":"First polish case of CSF1R-related leukoencephalopathy","volume":"55","author":"Wszolek","year":"2021","journal-title":"Neurol Neurochir Pol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1212\/WNL.0b013e3181a826c0","article-title":"Leukoencephalopathy with spheroids (HDLS) and pigmentary leukodystrophy (POLD): a single entity?","volume":"72","author":"Wider","year":"2009","journal-title":"Neurol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"2039","DOI":"10.1212\/01.wnl.0000436945.01023.ac","article-title":"De novo mutations in hereditary diffuse leukoencephalopathy with axonal spheroids (HDLS)","volume":"81","author":"Karle","year":"2013","journal-title":"Neurol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1007\/s00401-004-0847-x","article-title":"Adult onset leukodystrophy with neuroaxonal spheroids and pigmented glia: report of a family, historical perspective, and review of the literature","volume":"107","author":"Marotti","year":"2004","journal-title":"Acta Neuropathol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1097\/nen.0b013e3180986247","article-title":"A comparative morphologic analysis of adult onset leukodystrophy with neuroaxonal spheroids and pigmented glia\u2013a role for oxidative damage","volume":"66","author":"Ali","year":"2007","journal-title":"J Neuropathol Exp Neurol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1212\/WNL.0000000000000026","article-title":"Hereditary diffuse leukoencephalopathy with axonal spheroids: more than just a rare disease","volume":"82","author":"Wider","year":"2014","journal-title":"Neurol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1111\/ene.13125","article-title":"Clinical and genetic characterization of adult-onset leukoencephalopathy with axonal spheroids and pigmented glia associated with CSF1R mutation","volume":"24","author":"Konno","year":"2017","journal-title":"Eur J Neurol"},{"key":"B14","article-title":"CSF1R-Related adult-onset leukoencephalopathy with axonal spheroids and pigmented glia","volume-title":"Gene Reviews","author":"Sundal","year":"2012"},{"key":"B15","doi-asserted-by":"publisher","first-page":"S39","DOI":"10.1016\/j.parkreldis.2017.08.018","article-title":"Cognitive dysfunction and symptoms of movement disorders in adult-onset leukoencephalopathy with axonal spheroids and pigmented glia","volume":"46","author":"Ikeuchi","year":"2018","journal-title":"Parkinsonism Relat Disord"},{"key":"B16","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1177\/1971400918822136","article-title":"Adult-onset leukoencephalopathy with axonal spheroids and pigmented glia: clinical and imaging characteristics","volume":"32","author":"Makary","year":"2019","journal-title":"Neuroradiol J."},{"key":"B17","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s40035-019-0171-y","article-title":"Clinicopathologic characterization and abnormal autophagy of CSF1R- related leukoencephalopathy","volume":"8","author":"Tian","year":"2019","journal-title":"Transl Neurodegener."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1007\/s10072-018-3693-7","article-title":"A novel mutation in the CSF1R gene causes hereditary diffuse leukoencephalopathy with axonal spheroids","volume":"40","author":"Du","year":"2019","journal-title":"Neurol Sci"},{"key":"B19","first-page":"6093","article-title":"A novel dominant-negative mutation of the CSF1R gene causes adult-onset leukoencephalopathy with axonal spheroids and pigmented glia","volume":"11","author":"Leng","year":"2019","journal-title":"Am J Transl Res"},{"key":"B20","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1038\/ng.1027","article-title":"Mutations in the Colony Stimulating Factor 1 Receptor (CSF1R) gene cause hereditary diffuse leukoencephalopathy with spheroids","volume":"44","author":"Rademakers","year":"2011","journal-title":"Nat Genet"},{"key":"B21","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.jocn.2017.10.060","article-title":"Adult-onset leukoencephalopathy with axonal spheroids and pigmented glia (ALSP): integrating the literature on hereditary diffuse leukoencephalopathy with spheroids (HDLS) and pigmentary orthochromatic leukodystrophy (POLD)","volume":"48","author":"Adams","year":"2018","journal-title":"J Clin Neurosci."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.3174\/ajnr.A5744","article-title":"Adult-onset leukoencephalopathy with axonal spheroids and pigmented glia: an MRI study of 16 French cases","volume":"39","author":"Codjia","year":"2018","journal-title":"AJNR Am J Neuroradiol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"2415","DOI":"10.1007\/s00415-018-9017-2","article-title":"Identification and functional characterization of novel mutations including frameshift mutation in exon 4 of CSF1R in patients with adult-onset leukoencephalopathy with axonal spheroids and pigmented glia","volume":"265","author":"Miura","year":"2018","journal-title":"J Neurol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s10048-019-00579-0","article-title":"A novel CSF-1R mutation in a family with hereditary diffuse leukoencephalopathy with axonal spheroids misdiagnosed as hydrocephalus","volume":"20","author":"Wang","year":"2019","journal-title":"Neurogenetics."},{"key":"B25","doi-asserted-by":"publisher","first-page":"e00595","DOI":"10.1002\/mgg3.595","article-title":"Functional characterization of a novel CSF1R mutation causing hereditary diffuse leukoencephalopathy with spheroids","volume":"7","author":"Kraya","year":"2019","journal-title":"Mol Genet Genomic Med"},{"key":"B26","doi-asserted-by":"publisher","first-page":"491","DOI":"10.3389\/fgene.2019.00491","article-title":"A novel splicing mutation in the CSF1R gene in a family with hereditary diffuse leukoencephalopathy with axonal spheroids","volume":"10","author":"Yang","year":"2019","journal-title":"Front Genetics."},{"key":"B27","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1093\/brain\/awz390","article-title":"Allogeneic HSCT for adult-onset leukoencephalopathy with spheroids and pigmented glia","volume":"143","author":"Gelfand","year":"2020","journal-title":"Brain."},{"key":"B28","doi-asserted-by":"publisher","first-page":"104867","DOI":"10.1016\/j.nbd.2020.104867","article-title":"Altered features of monocytes in adult-onset leukoencephalopathy with axonal spheroids and pigmented glia: a clue to the pathomechanism of microglial dyshomeostasis","volume":"140","author":"Hamatani","year":"2020","journal-title":"Neurobiol Dis."},{"key":"B29","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s40478-020-00947-0","article-title":"Loss of homeostatic microglial phenotype in CSF1R-related leukoencephalopathy","volume":"8","author":"Kempthorne","year":"2020","journal-title":"Acta Neuropathol Commun"},{"key":"B30","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1111\/ene.14086","article-title":"Factors predictive of the presence of a CSF1R mutation in patients with leukoencephalopathy","volume":"27","author":"Kondo","year":"2020","journal-title":"Eur J Neurol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"11","DOI":"10.21037\/atm.2019.12.17","article-title":"Clinical features and genetic characteristics of hereditary diffuse leukoencephalopathy with spheroids due to CSF1R mutation: a case report and literature review","volume":"8","author":"Zhuang","year":"2020","journal-title":"Ann Transl Med."},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1111\/febs.16085.","article-title":"Modeling CSF-1 receptor deficiency diseases-how close are we?","author":"Chitu","year":"2021","journal-title":"FEBS J."},{"key":"B33","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1111\/ene.12572","article-title":"Hereditary diffuse leukoencephalopathy with spheroids with phenotype of primary progressive multiple sclerosis","volume":"22","author":"Sundal","year":"2015","journal-title":"Eur J Neurol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1038\/nrneurol.2010.17-c1","article-title":"Nasu-Hakola disease and primary microglial dysfunction","volume":"6","author":"Bianchin","year":"2010","journal-title":"Nat Rev Neurol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1038\/nrn3722","article-title":"Microglia and brain macrophages in the molecular age: from origin to neuropsychiatric disease","volume":"15","author":"Prinz","year":"","journal-title":"Nat Rev Neurosci. ("},{"key":"B36","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1007\/s00401-017-1739-1","article-title":"Leukodystrophies: a proposed classification system based on pathological changes and pathogenetic mechanisms","volume":"134","author":"van der Knaap","year":"2017","journal-title":"Acta Neuropathol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"e00582","DOI":"10.1002\/mgg3.582","article-title":"AARS2 leukoencephalopathy: a new variant of mitochondrial encephalomyopathy","volume":"7","author":"Tang","year":"2019","journal-title":"Mol Genet Genomic Med"},{"key":"B38","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1111\/nan.12046","article-title":"A clinicopathological and genetic study of sporadic diffuse leukoencephalopathy with spheroids: a report of two cases","volume":"39","author":"Kimura","year":"2013","journal-title":"Neuropathol Appl Neurobiol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1111\/his.12741","article-title":"Sporadic adult-onset leucodystrophy with axonal spheroids and pigmented glia with no mutations in the known targeted genes","volume":"68","author":"Fern\u00e1ndez-Vega","year":"2016","journal-title":"Histopathology"},{"key":"B40","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1136\/jnnp-2015-310788","article-title":"Hereditary leukoencephalopathy with axonal spheroids: a spectrum of phenotypes from CNS vasculitis to parkinsonism in an adult onset leukodystrophy series","volume":"87","author":"Lynch","year":"2016","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"B41","doi-asserted-by":"publisher","first-page":"e135","DOI":"10.1212\/NXG.0000000000000135","article-title":"Redefining the phenotype of ALSP and AARS2 mutation-related leukodystrophy","volume":"3","author":"Lakshmanan","year":"2017","journal-title":"Neurol Genet."},{"key":"B42","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.1212\/WNL.0000000000000497","article-title":"Novel (ovario) leukodystrophy related to AARS2 mutations","volume":"82","author":"Dallabona","year":"2014","journal-title":"Neurol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1016\/j.celrep.2018.06.113","article-title":"Colony-stimulating factor 1 receptor (CSF1R) regulates microglia density and distribution, but not microglia differentiation in vivo","volume":"24","author":"Oosterhof","year":"2018","journal-title":"Cell Rep"},{"key":"B44","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1016\/j.ajhg.2019.03.010","article-title":"Homozygous mutations in CSF1R cause a pediatric-onset leukoencephalopathy and can result in congenital absence of microglia","volume":"104","author":"Oosterhof","year":"2019","journal-title":"Am J Hum Genet"},{"key":"B45","doi-asserted-by":"publisher","first-page":"e51796","DOI":"10.7554\/eLife.51796.sa2","article-title":"A MAC2-positive progenitor-like microglial population is resistant to CSF1R inhibition in adult mouse brain","volume":"9","author":"Zhan","year":"2020","journal-title":"Elife."},{"key":"B46","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1038\/s41591-019-0695-9","article-title":"Human and mouse single-nucleus transcriptomics reveal TREM2-dependent and TREM2-independent cellular responses in Alzheimer's disease","volume":"26","author":"Zhou","year":"2020","journal-title":"Nat Med"},{"key":"B47","doi-asserted-by":"publisher","first-page":"e12889","DOI":"10.15252\/emmm.202012889","article-title":"Attenuated CSF-1R signalling drives cerebrovascular pathology","volume":"13","author":"Delaney","year":"2021","journal-title":"EMBO Mol Med."},{"key":"B48","doi-asserted-by":"publisher","first-page":"2901","DOI":"10.1002\/mds.28734","article-title":"Treatment of CSF1R-related leukoencephalopathy: breaking new ground","volume":"36","author":"Tipton","year":"2021","journal-title":"Mov Disord."},{"key":"B49","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1212\/01.wnl.0000325916.30701.21","article-title":"Insights into the dynamics of hereditary diffuse leukoencephalopathy with axonal spheroids","volume":"71","author":"Van Gerpen","year":"2008","journal-title":"Neurol"},{"key":"B50","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1212\/WNL.0b013e318263575a","article-title":"MRI characteristics and scoring in HDLS due to CSF1R gene mutations","volume":"79","author":"Sundal","year":"2012","journal-title":"Neurol"},{"key":"B51","doi-asserted-by":"publisher","first-page":"2351","DOI":"10.1007\/s00415-014-7509-2","article-title":"Imaging features in conventional MRI, spectroscopy and diffusion weighted images of hereditary diffuse leukoencephalopathy with axonal spheroids (HDLS)","volume":"261","author":"Bender","year":"2014","journal-title":"J Neurol"},{"key":"B52","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1212\/WNL.0000000000000046","article-title":"Haploinsufficiency of CSF-1R and clinicopathologic characterization in patients with HDLS","volume":"82","author":"Konno","year":"2014","journal-title":"Neurol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1111\/ene.13464","article-title":"Diagnostic criteria for adult-onset leukoencephalopathy with axonal spheroids and pigmented glia due to CSF1R mutation","volume":"25","author":"Konno","year":"2018","journal-title":"Eur J Neurol"},{"key":"B54","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1111\/bpa.12443","article-title":"Adult-onset leukoencephalopathy with axonal spheroids and pigmented glia (ALSP) and Nasu-Hakola disease: lesion staging and dynamic changes of axons and microglial subsets","volume":"27","author":"Oyanagi","year":"2017","journal-title":"Brain Pathol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"521","DOI":"10.5692\/clinicalneurol.cn-001072","article-title":"Adult-onset leukoencephalopathy with axonal spheroids and pigmented glia: a case presented brain calcification and corpus callosum atrophy from over 10 years before the onset of dementia","volume":"57","author":"Okamoto","year":"2017","journal-title":"Rinsho Shinkeigaku"},{"key":"B56","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1007\/s00415-018-8765-3","article-title":"Diffusion tensor imaging in metachromatic leukodystrophy","volume":"265","author":"van Rappard","year":"2018","journal-title":"J Neurol"},{"key":"B57","doi-asserted-by":"publisher","first-page":"6683","DOI":"10.1039\/C3CS60430F","article-title":"PET\/SPECT imaging agents for neurodegenerative diseases","volume":"43","author":"Zhu","year":"2014","journal-title":"Chem Soc Rev"},{"key":"B58","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1001\/jamaneurol.2013.698","article-title":"Genetic analysis of inherited leukodystrophies: genotype-phenotype correlations in the CSF1R gene","volume":"70","author":"Guerreiro","year":"2013","journal-title":"JAMA Neurol"},{"key":"B59","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1186\/s12883-016-0694-0","article-title":"Involvement of the optic nerve in mutated CSF1R-induced hereditary diffuse leukoencephalopathy with axonal spheroids","volume":"16","author":"Shu","year":"2016","journal-title":"BMC Neurol"},{"key":"B60","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1136\/jnnp-2013-305888","article-title":"A practical approach to diagnosing adult onset leukodystrophies","volume":"85","author":"Ahmed","year":"2014","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"B61","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.neurobiolaging.2018.01.015","article-title":"Mendelian adult-onset leukodystrophy genes in Alzheimer's disease: critical influence of CSF1R and NOTCH3","volume":"66","author":"Sassi","year":"2018","journal-title":"Neurobiol Aging"},{"key":"B62","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.jns.2011.10.006","article-title":"Hereditary diffuse leukoencephalopathy with axonal spheroids (HDLS): a misdiagnosed disease entity","volume":"314","author":"Sundal","year":"2012","journal-title":"J Neurol Sci"},{"key":"B63","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1017\/cjn.2018.354","article-title":"Looking glass syndromes: two sides of the same gene","volume":"46","author":"Taylor","year":"2019","journal-title":"Can J Neurol Sci"},{"key":"B64","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1038\/nrneurol.2017.175","article-title":"Adult leukodystrophies","volume":"14","author":"Kohler","year":"2018","journal-title":"Nat Rev Neurol."},{"key":"B65","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1007\/s10072-019-04116-7","article-title":"Biopsy histopathology in the diagnosis of adult-onset leukoencephalopathy with axonal spheroids and pigmented glia (ALSP)","volume":"41","author":"Mao","year":"2020","journal-title":"Neurol Sci."},{"key":"B66","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1148\/rg.2019180081","article-title":"Adult Leukodystrophies: a step-by-step diagnostic approach","volume":"39","author":"Resende","year":"2019","journal-title":"Radiographics"},{"key":"B67","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1212\/WNL.0000000000006357","article-title":"NfL is a biomarker for adult-onset leukoencephalopathy with axonal spheroids and pigmented glia","volume":"91","author":"Hayer","year":"2018","journal-title":"Neurol."},{"key":"B68","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1016\/j.parkreldis.2013.05.013","article-title":"Parkinsonian features in hereditary diffuse leukoencephalopathy with spheroids (HDLS) and CSF1R mutations","volume":"19","author":"Sundal","year":"2013","journal-title":"Parkinsonism Relat Disord"},{"key":"B69","doi-asserted-by":"publisher","first-page":"4224","DOI":"10.1111\/bph.14030","article-title":"Beyond symptomatic effects: potential of donepezil as a neuroprotective agent and disease modifier in Alzheimer's disease","volume":"74","author":"Kim","year":"2017","journal-title":"Br J Pharmacol"},{"key":"B70","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.1093\/brain\/aww066","article-title":"CSF1R mosaicism in a family with hereditary diffuse leukoencephalopathy with spheroids","volume":"139","author":"Eichler","year":"2016","journal-title":"Brain"},{"key":"B71","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1136\/jnnp-2019-320701","article-title":"Hematopoietic stem cell transplantation in CSF1R-related adult-onset leukoencephalopathy with axonal spheroids and pigmented glia","volume":"90","author":"Mochel","year":"2019","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"B72","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1002\/mds.28515","article-title":"Pre-symptomatic immunosuppression protective in CSF1R-related leukoencephalopathy","volume":"36","author":"Tipton","year":"2021","journal-title":"Mov Disord."},{"key":"B73","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/S1474-4422(17)30124-2","article-title":"Neurofilament light protein in blood as a potential biomarker of neurodegeneration in Huntington's disease: a retrospective cohort analysis","volume":"16","author":"Byrne","year":"2017","journal-title":"Lancet Neurol."},{"key":"B74","doi-asserted-by":"publisher","first-page":"e0172762","DOI":"10.1371\/journal.pone.0172762","article-title":"Tau or neurofilament light-Which is the more suitable biomarker for Huntington's disease?","volume":"12","author":"Niemel\u00e4","year":"2017","journal-title":"PLoS ONE"},{"key":"B75","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1002\/ana.25276","article-title":"Neurofilament light: a candidate biomarker of presymptomatic amyotrophic lateral sclerosis and phenoconversion","volume":"84","author":"Benatar","year":"2018","journal-title":"Ann Neurol."},{"key":"B76","doi-asserted-by":"publisher","first-page":"2241","DOI":"10.2147\/NDT.S173280","article-title":"Neurofilament light chain as a biological marker for multiple sclerosis: a meta-analysis study","volume":"14","author":"Cai","year":"2018","journal-title":"Neuropsychiatr Dis Treat"},{"key":"B77","doi-asserted-by":"publisher","first-page":"e518","DOI":"10.1212\/WNL.0000000000004932","article-title":"Plasma neurofilament light chain concentration in the inherited peripheral neuropathies","volume":"90","author":"Sandelius","year":"2018","journal-title":"Neurol"},{"key":"B78","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.trci.2019.02.004","article-title":"Differential effects of neurodegeneration biomarkers on subclinical cognitive decline","volume":"5","author":"Merluzzi","year":"2019","journal-title":"Alzheimers Dement."},{"key":"B79","doi-asserted-by":"publisher","first-page":"e1007","DOI":"10.1212\/WNL.0000000000007032","article-title":"Blood neurofilament light chain as a biomarker of MS disease activity and treatment response","volume":"92","author":"Kuhle","year":"2019","journal-title":"Neurol"},{"key":"B80","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s13024-019-0338-0","article-title":"Neurofilament light chain is a promising serum biomarker in spinocerebellar ataxia type 3","volume":"14","author":"Li","year":"2019","journal-title":"Mol Neurodegener"},{"key":"B81","doi-asserted-by":"publisher","first-page":"e827","DOI":"10.1212\/WNL.0000000000010084","article-title":"NfL as a biomarker for neurodegeneration and survival in Parkinson disease","volume":"95","author":"B\u00e4ckstr\u00f6m","year":"2020","journal-title":"Neurol."},{"key":"B82","doi-asserted-by":"publisher","first-page":"9161","DOI":"10.1038\/s41598-020-66090-x","article-title":"Differential levels of neurofilament light protein in cerebrospinal fluid in patients with a wide range of neurodegenerative disorders","volume":"10","author":"Delaby","year":"2020","journal-title":"Sci Rep."},{"key":"B83","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.1002\/acn3.51188","article-title":"Plasma NfL and GFAP as biomarkers of spinal cord degeneration in adrenoleukodystrophy","volume":"7","author":"van Ballegoij","year":"2020","journal-title":"Ann Clin Transl Neurol"},{"key":"B84","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1111\/ene.14063","article-title":"Serum neurofilament light chain at time of diagnosis is an independent prognostic factor of survival in amyotrophic lateral sclerosis","volume":"27","author":"Thouvenot","year":"2020","journal-title":"Eur J Neurol"},{"key":"B85","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.1038\/s41467-021-22114-2","article-title":"Neurofilament light chain as a potential biomarker for monitoring neurodegeneration in X-linked adrenoleulodystrophy","volume":"12","author":"Weinhofer","year":"2021","journal-title":"Nat Commun."},{"key":"B86","doi-asserted-by":"publisher","first-page":"363","DOI":"10.2217\/17520363.2.4.363","article-title":"Tau as a biomarker of neurodegenerative diseases","volume":"2","author":"Schraen-Maschke","year":"2008","journal-title":"Biomark Med"},{"key":"B87","first-page":"1141","article-title":"Tau protein in neurodegenerative diseases - a review","volume":"58","author":"P\u00eer\u015fcoveanu","year":"2017","journal-title":"Rom J Morphol Embryol."},{"key":"B88","doi-asserted-by":"publisher","first-page":"175","DOI":"10.21037\/atm.2018.04.23","article-title":"Tau in neurodegenerative disease","volume":"6","author":"Gao","year":"2018","journal-title":"Ann Transl Med"},{"key":"B89","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.annemergmed.2011.08.021","article-title":"Elevated levels of serum glial fibrillary acidic protein breakdown products in mild and moderate traumatic brain injury are associated with intracranial lesions and neurosurgical intervention","volume":"59","author":"Papa","year":"2012","journal-title":"Ann Emerg Med."},{"key":"B90","doi-asserted-by":"publisher","first-page":"e363","DOI":"10.1016\/j.bbmt.2019.09.003","article-title":"Hematopoietic stem cell transplantation to treat leukodystrophies: clinical practice guidelines from the Hunter's Hope Leukodystrophy Care Network","volume":"25","author":"Page","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"key":"B91","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1186\/s40478-020-01093-3","article-title":"Microglial replacement therapy: a potential therapeutic strategy for incurable CSF1R-related leukoencephalopathy","volume":"8","author":"Han","year":"2020","journal-title":"Acta Neuropathol Commun"},{"key":"B92","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.1073\/pnas.1812155116","article-title":"PET imaging of microglia by targeting macrophage colony-stimulating factor 1 receptor (CSF1R)","volume":"116","author":"Horti","year":"2019","journal-title":"Proc Natl Acad Sci USA."},{"key":"B93","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1002\/ana.24754","article-title":"Characteristic microglial features in patients with hereditary diffuse leukoencephalopathy with spheroids","volume":"80","author":"Tada","year":"2016","journal-title":"Ann Neurol"},{"key":"B94","doi-asserted-by":"publisher","first-page":"206","DOI":"10.3389\/fncel.2018.00206","article-title":"Microglial TREM2\/DAP12 signaling: a double-edged sword in neural diseases","volume":"12","author":"Konishi","year":"2018","journal-title":"Front Cell Neurosci"},{"key":"B95","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1038\/nri1106","article-title":"TREMs in the immune system and beyond","volume":"3","author":"Colona","year":"2003","journal-title":"Nat Rev Immunol."},{"key":"B96","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1021\/acschemneuro.5b00313","article-title":"TREM2 function in Alzheimer's disease and neurodegeneration","volume":"7","author":"Ulrich","year":"2016","journal-title":"ACS Chem Neurosci"},{"key":"B97","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1038\/s41582-018-0072-1","article-title":"TREM2-a key player in microglial biology and Alzheimer disease","volume":"14","author":"Ulland","year":"2018","journal-title":"Nat Rev Neurol"},{"key":"B98","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1016\/j.cell.2020.05.003","article-title":"The physiology, pathology, and potential therapeutic applications of the TREM2 signaling pathway","volume":"181","author":"Deczkowska","year":"2020","journal-title":"Cell."},{"key":"B99","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1177\/1756285612455733","article-title":"Assessment scales in dementia","volume":"5","author":"Sheehan","year":"2012","journal-title":"Ther Adv Neurol Disord"},{"key":"B100","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1177\/070674370705200508","article-title":"The montreal cognitive assessment: validity and utility in a memory clinic setting","volume":"52","author":"Smith","year":"2007","journal-title":"Can J Psychiatry"},{"key":"B101","doi-asserted-by":"publisher","first-page":"2501","DOI":"10.1002\/mds.23362","article-title":"A recommended scale for cognitive screening in clinical trials of Parkinson's disease","volume":"25","author":"Chou","year":"2010","journal-title":"Mov Disord"},{"key":"B102","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1111\/j.1532-5415.2005.53221.x","article-title":"The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment","volume":"53","author":"Nasreddine","year":"2005","journal-title":"J Am Geriatr Soc"},{"key":"B103","first-page":"12","article-title":"Cognitive screening tools","volume":"23","author":"Segal-Gidan","year":"2013","journal-title":"Clin Rev"},{"key":"B104","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","article-title":"\u201cMini-mental state\u201d. A practical method for grading the cognitive state of patients for the clinician","volume":"12","author":"Folstein","year":"1975","journal-title":"J Psychiatr Res"},{"key":"B105","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1046\/j.1532-5415.2003.51465.x","article-title":"The Mini-Cog as a screen for dementia: validation in a population-based sample","volume":"51","author":"Borson","year":"2003","journal-title":"J Am Geriatr Soc"},{"key":"B106","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1159\/000457119","article-title":"Association between Montreal Cognitive Assessment sub-item scores and corresponding cognitive test performance in patients with frontotemporal dementia and related disorders","volume":"43","author":"Coleman","year":"2017","journal-title":"Dement Geriatr Cogn Disord."},{"key":"B107","doi-asserted-by":"publisher","first-page":"2277","DOI":"10.1038\/nprot.2006.390","article-title":"Administration and interpretation of the Trail Making Test","volume":"1","author":"Bowie","year":"2006","journal-title":"Nat Protoc"},{"key":"B108","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/B978-0-12-802219-1.00005-5","article-title":"Chapter 5 executive, theory of mind and adaptive behavior","volume-title":"Psychometrics and Psychologics Assessment.","author":"Coulacoglou","year":"2017"},{"key":"B109","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1177\/1352458517690821","article-title":"Validity of the symbol digit modalities test as a cognition performance outcome measure for multiple sclerosis","volume":"23","author":"Benedict","year":"2017","journal-title":"Mult Scler."},{"key":"B110","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41746-021-00401-y","article-title":"Smartphone-based symbol-digit modalities test reliably captures brain damage in multiple sclerosis","volume":"4","author":"Pham","year":"2021","journal-title":"NPJ Digital Med"},{"key":"B111","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1176\/appi.neuropsych.14060139","article-title":"Verbal fluency as a rapid screening test for cognitive impairment in early Parkinson's disease","volume":"27","author":"Torralva","year":"2015","journal-title":"J Neuropsychiatry Clin Neurol."},{"key":"B112","doi-asserted-by":"publisher","first-page":"557","DOI":"10.3389\/fpsyg.2017.00557","article-title":"The stroop color and word Test","volume":"8","author":"Scarpina","year":"2017","journal-title":"Front Psychol"},{"key":"B113","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1097\/01.JGP.0000221510.33817.86","article-title":"Comparison of the Saint Louis University mental status examination and the mini-mental state examination for detecting dementia and mild neurocognitive disorder\u2013a pilot study","volume":"14","author":"Tariq","year":"2006","journal-title":"Am J Geriatr Psychiatry"},{"key":"B114","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1212\/WNL.52.2.231","article-title":"Screening for dementia with the memory impairment screen","volume":"52","author":"Buschke","year":"1999","journal-title":"Neurol"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.4088\/PCC.12m01435","article-title":"The predictive value of the memory impairment screen in patients with subjective memory complaints: a prospective study","volume":"15","author":"Modrego","year":"2013","journal-title":"Prim Care Companion CNS Disord."},{"key":"B116","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1590\/1980-57642016dn11-010003","article-title":"Scoring systems for the Clock Drawing Test: a historical review","volume":"11","author":"Spenciere","year":"2017","journal-title":"Dement Neuropsychol"},{"key":"B117","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1192\/bjp.140.6.566","article-title":"A new clinical scale for the staging of dementia","volume":"140","author":"Hughes","year":"1982","journal-title":"Br J Psychiatry"},{"key":"B118","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.jalz.2019.05.013","article-title":"Use of the CDR\u00ae plus NACC FTLD in mild FTLD: data from the ARTFL\/LEFFTDS consortium","volume":"16","author":"Miyagawa","year":"2020","journal-title":"Alzheimers Dement"},{"key":"B119","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1080\/j.1440-1614.2006.01923.x","article-title":"The NUCOG: validity and reliability of a brief cognitive screening tool in neuropsychiatric patients","volume":"40","author":"Walterfang","year":"2006","journal-title":"Aust N Z J Psychiatry"},{"key":"B120","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1002\/mds.22340","article-title":"Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results","volume":"23","author":"Goetz","year":"2008","journal-title":"Mov Disord"},{"key":"B121","doi-asserted-by":"publisher","first-page":"S80","DOI":"10.29399\/npa.23412","article-title":"Neurostatus and EDSS calculation with cases","volume":"55","author":"Sen","year":"2018","journal-title":"Noro Psikiyatr Ars"},{"key":"B122","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.ejpn.2018.10.001","article-title":"Two-minute versus 6-minute walk distances during 6-minute walk test in neuromuscular disease: Is the 2-minute walk test an effective alternative to a 6-minute walk test?","volume":"23","author":"Witherspoon","year":"2019","journal-title":"Eur J Paediatr Neurol."},{"key":"B123","doi-asserted-by":"publisher","first-page":"409","DOI":"10.2147\/JMDH.S142520","article-title":"Timed up and go test combined with self-rated multifactorial questionnaire on falls risk and sociodemographic factors predicts falls among community-dwelling older adults better than the timed up and go test on its own","volume":"10","author":"Ibrahim","year":"2017","journal-title":"J Multidiscip Healthc"},{"key":"B124","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1212\/01.wnl.0000228242.53336.90","article-title":"The Spastic Paraplegia Rating Scale (SPRS): a reliable and valid measure of disease severity","volume":"67","author":"Sch\u00fcle","year":"2006","journal-title":"Neurol"},{"key":"B125","first-page":"231","article-title":"The interrater and intrarater reliability of the Modified Ashworth Scale in the assessment of muscle spasticity: limb and muscle group effect","volume":"23","author":"Ansari","year":"2008","journal-title":"Neuro Rehabilitation"},{"key":"B126","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1007\/BF01530764","article-title":"Goal attainment scaling: a general method for evaluating comprehensive community mental health programs","volume":"4","author":"Kiresuk","year":"1968","journal-title":"Community Ment Health J"},{"key":"B127","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1177\/0269215517692641","article-title":"Electronic visual analogue scales for pain, fatigue, anxiety and quality of life in people with multiple sclerosis using smartphone and tablet: a reliability and feasibility study","volume":"31","author":"Kos","year":"2017","journal-title":"Clin Rehabil."},{"key":"B128","first-page":"28","article-title":"The clinical global impressions scale: applying a research tool in clinical practice","volume":"4","author":"Busner","year":"2007","journal-title":"Psychiatry."},{"key":"B129","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1136\/jnnp.74.6.710","article-title":"Using the SF-36 measure to compare the health impact of multiple sclerosis and Parkinson's disease with normal population health profiles","volume":"74","author":"Riazi","year":"2003","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B130","doi-asserted-by":"publisher","first-page":"1941034","DOI":"10.1155\/2016\/1941034","article-title":"Reliability of three disability scales for detection of independence loss in Parkinson's disease","volume":"2016","author":"Bjornestad","year":"2016","journal-title":"Parkinsons Dis."},{"key":"B131","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/j.psychres.2010.04.030","article-title":"Earliest functional declines in Huntington disease","volume":"178","author":"Beglinger","year":"2010","journal-title":"Psychiatry Res."},{"key":"B132","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/1472-6947-13-72","article-title":"Appraisal of the karnofsky performance status and proposal of a simple algorithmic system for its evaluation","volume":"13","author":"P\u00e9us","year":"2013","journal-title":"BMC Med Inform Decis Mak."},{"key":"B133","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.parkreldis.2020.08.021","article-title":"The Cortical Basal ganglia Functional Scale (CBFS): development and preliminary validation","volume":"79","author":"Lang","year":"2020","journal-title":"Parkinsonism Relat Disord"},{"key":"B134","doi-asserted-by":"publisher","first-page":"e65640","DOI":"10.1371\/journal.pone.0065640","article-title":"How people with multiple sclerosis rate their quality of life: an EQ-5D survey via the UK MS register","volume":"8","author":"Jones","year":"2013","journal-title":"PLoS ONE."},{"key":"B135","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","article-title":"A rating scale for depression","volume":"23","author":"Hamilton","year":"1960","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B136","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1159\/000506879","article-title":"The Hamilton Rating Scales for depression: a critical review of clinimetric properties of different versions","volume":"89","author":"Carrozzino","year":"2020","journal-title":"Psychother Psychosom"},{"key":"B137","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1001\/archpsyc.1961.01710120031004","article-title":"An inventory for measuring depression","volume":"4","author":"Beck","year":"1961","journal-title":"Arch Gen Psychiatry"},{"key":"B138","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/0272-7358(88)90050-5","article-title":"Psychometric properties of the Beck Depression Inventory: twenty-five years of evaluation","volume":"8","author":"Beck","year":"1988","journal-title":"Clin Psych Rev"},{"key":"B139","doi-asserted-by":"publisher","first-page":"2308","DOI":"10.1212\/WNL.44.12.2308","article-title":"The neuropsychiatric inventory: comprehensive assessment of psychopathology in dementia","volume":"44","author":"Cummings","year":"1994","journal-title":"Neurol."},{"key":"B140","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1177\/1352458509347150","article-title":"Validation of the hospital anxiety and depression scale for use with multiple sclerosis patients","volume":"15","author":"Honarmand","year":"2009","journal-title":"Mult Scler"},{"key":"B141","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1023\/A:1009530711710","article-title":"Factor structure of the burden interview","volume":"6","author":"Knight","year":"2000","journal-title":"J Clin Geropsychology."},{"key":"B142","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.jagp.2012.09.006","article-title":"Dimensions of caregiver burden in dementia: impact of demographic, mood, and care recipient variables","volume":"22","author":"Springate","year":"2014","journal-title":"Am J Geriatr Psychiatry"},{"key":"B143","doi-asserted-by":"publisher","first-page":"2333721417700759","DOI":"10.1177\/2333721417700759","article-title":"Patient-centered outcomes research and patient -centered care for older adults","volume":"3","author":"Jayadevappa","year":"2017","journal-title":"Gerontol Geriatr Med."},{"key":"B144","first-page":"1761","article-title":"Adrenoleukodystrophy: a scoring method for brain MR observations","volume":"15","author":"Loes","year":"1994","journal-title":"AJNR Am J Neuroradiol"},{"key":"B145","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1002\/ana.25705","article-title":"Validation of rapid magnetic resonance myelin imaging in multiple sclerosis","volume":"87","author":"Ouellette","year":"2020","journal-title":"Ann Neurol"},{"key":"B146","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.1109\/JBHI.2015.2461555","article-title":"An emerging era in the management of Parkinson's disease: wearable technologies and the internet of things","volume":"19","author":"Pasluosta","year":"2015","journal-title":"IEEE J Biomed Health Inform"},{"key":"B147","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1109\/JIOT.2015.2394696","article-title":"Guest editorial: special issue on internet of things for smart and connected health","volume":"2","author":"Wang","year":"2015","journal-title":"IEEE Internet Things J"},{"key":"B148","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1002\/mds.26642","article-title":"Technology in Parkinson's disease: challenges and opportunities","volume":"31","author":"Espay","year":"2016","journal-title":"Mov Disord"},{"key":"B149","doi-asserted-by":"publisher","first-page":"103153","DOI":"10.1016\/j.jbi.2019.103153","article-title":"Wearable activity trackers, accuracy, adoption, acceptance and health impact: a systematic literature review","volume":"93","author":"Shin","year":"2019","journal-title":"J Biomed Inform"},{"key":"B150","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1111\/j.1365-2869.2011.00917.x","article-title":"Comparison of actigraphy with polysomnography and sleep logs in depressed insomniacs","volume":"21","author":"McCall","year":"2012","journal-title":"J Sleep Res"},{"key":"B151","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1016\/j.parkreldis.2015.04.016","article-title":"Continuous non-invasive monitoring to detect covert autonomic dysfunction in Parkinson's disease","volume":"21","author":"Hellman","year":"2015","journal-title":"Parkinsonism Relat Disord"},{"key":"B152","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1007\/s00702-015-1393-5","article-title":"Heart rate variability shows different cardiovascular modulation in Parkinson's disease patients with tremor dominant subtype compared to those with a kinetic rigid dominant subtype","volume":"122","author":"Solla","year":"2015","journal-title":"J Neural Transm"},{"key":"B153","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1002\/mds.26165","article-title":"Diminished event-related cortical arousals and altered heart rate response in Parkinson's disease","volume":"30","author":"Sommerauer","year":"2015","journal-title":"Mov Disord."},{"key":"B154","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.snb.2015.08.073","article-title":"Optical monitoring of sweat pH by a textile fabric wearable sensor based on covalently bonded litmus-3- glycidoxypropyltrimethoxysilane coating","volume":"222","author":"Caldara","year":"2016","journal-title":"Sens Actuators B Chem"},{"key":"B155","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.snb.2015.10.114","article-title":"Physiological stress monitoring using sodium ion potentiometric microsensors for sweat analysis","volume":"225","author":"Cazal\u00e9","year":"2016","journal-title":"Sen Actuators B Chem."},{"key":"B156","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.snb.2015.12.034","article-title":"A wearable conductivity sensor for wireless real-time sweat monitoring","volume":"227","author":"Liu","year":"2016","journal-title":"Sen Actuators B Chem"},{"key":"B157","volume-title":"Financial Incentives to Encourage Development of Therapies That Address Unmet Medical Needs for Nervous System Disorders: Workshop Summary.","year":"2015"},{"key":"B158","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1093\/eurpub\/ckv065","article-title":"Unmet care needs of people with a neurological chronic disease: a cross-sectional study in Italy on Multiple Sclerosis","volume":"25","author":"Ponzio","year":"2015","journal-title":"Eur J Public Health"},{"key":"B159","doi-asserted-by":"publisher","first-page":"54","DOI":"10.3109\/21678421.2014.951946","article-title":"Financial cost of amyotrophic lateral sclerosis: a case study","volume":"16","author":"Obermann","year":"2015","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"B160","doi-asserted-by":"publisher","first-page":"2049","DOI":"10.1212\/WNL.0000000000004614","article-title":"The social and economic burden of frontotemporal degeneration","volume":"89","author":"Galvin","year":"2017","journal-title":"Neurol"},{"key":"B161","doi-asserted-by":"publisher","DOI":"10.1177\/2055217318822134","article-title":"Cognitive function predicts work disability among multiple sclerosis patients","volume":"5","author":"Kavaliunas","year":"2019","journal-title":"Mult Scler J Exp Transl Clin"},{"key":"B162","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1177\/1352458517740212","article-title":"Cognitive function is a major determinant of income among multiple sclerosis patients in Sweden acting independently from physical disability","volume":"25","author":"Kavaliunas","year":"2019","journal-title":"Mult Scler"},{"key":"B163","doi-asserted-by":"publisher","first-page":"e0169460","DOI":"10.1371\/journal.pone.0169460","article-title":"Income in multiple sclerosis patients with different disease phenotypes","volume":"12","author":"Kavaliunas","year":"2017","journal-title":"PLoS ONE."}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2021.788168\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,3]],"date-time":"2022-02-03T05:30:07Z","timestamp":1643866207000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2021.788168\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,3]]},"references-count":163,"alternative-id":["10.3389\/fneur.2021.788168"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2021.788168","relation":{"has-part":[{"id-type":"doi","id":"https:\/\/doi.org\/10.3389\/fneur.2021.788168.s001","asserted-by":"subject"}]},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,3]]},"article-number":"788168"}}